"La Polyclinique du Parc située à Caen est une clinique Médecine Chirurgie Obstétrique disposant d’une capacité de 250 lits et places. Elle regroupe une centaine de médecins et près de 500 collaborateurs. Nous disposons d'une maternité de niveau 2A avec service de Néonatologie et d'un service d'urgences 24/24."

During the past decade, Polyclinique du Parc conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique du Parc" #1 sponsor was "Centre Francois Baclesse" with 2 trials, followed by "Centre Henri Becquerel" with 1 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored, "Corin" with 1 trials sponsored and "EBMT Solid Tumors Working Party" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique du Parc" #1 collaborator was "Lymphoma Trials Office" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator and "Groupement Interrégional de Recherche Clinique et d'Innovation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique du Parc" are "Breast Cancer" (2 trials), "Lymphoma" (2 trials), "Arthritis" (1 trials), "Avascular Necrosis" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Polyclinique du Parc" in a lesser frequency.

Most popular intervention types in "Polyclinique du Parc" are "Drug" (5 trials), "Other" (4 trials), "Biological" (2 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "etoposide" (2 trials), "filgrastim" (2 trials), "radiation therapy" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique du Parc" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Polyclinique du Parc". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Polyclinique du Parc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique du Parc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".